This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
Physician payments are down slightly across the board, but they've fallen significantly for a handful of specialties. Researchers examined the long-term impact this trend could have on patient care.
Infectious disease experts are ratcheting up their watchfulness of the H5N1 influenza virus. That’s because the strain of “bird flu” has continued turning up in domestic livestock.
Key collaborators across the healthcare AI life cycle now have a common set of principles to which they can hold each other. And that means everyone from developers and researchers to providers, regulators and even patients.
Two-fifths of leaders at academic medical centers, 41%, see reducing average length of patient stay as far and away the No. 1 “most untapped” strategy to turn around falling operating margins.
A new study from researchers at Cedars-Sinai Medical Center should put minds at ease that the conservative management approach will not result in litigation when guidelines are followed.
Providers and payers disagree on a lot of things. But the camps are united in their appreciation of workers who have skills relevant to advancing GenAI in healthcare.
Critics say the model caters to the wealthy while taking primary care physicians out of circulation for everyone else. Not so, respond concierge proponents.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.